These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31680037)

  • 1. Chorea-like symptoms and high blood concentration of ceftriaxone in a patient undergoing hemodialysis: A case report.
    Yokoyama Y; Hosokawa N; Kudo T; Goda H; Ito K; Suzuki M; Funakoshi R
    J Infect Chemother; 2020 Mar; 26(3):285-288. PubMed ID: 31680037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ceftriaxione, a third-generation cephalosporin, in pediatric patients.
    Fukumoto K; Aida S; Oishi T; Ueno K
    Biol Pharm Bull; 2009 Jul; 32(7):1139-41. PubMed ID: 19571374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ceftriaxone in patients undergoing continuous renal replacement therapy.
    Goto K; Sato Y; Yasuda N; Hidaka S; Suzuki Y; Tanaka R; Kaneko T; Nonoshita K; Itoh H
    J Basic Clin Physiol Pharmacol; 2016 Nov; 27(6):625-631. PubMed ID: 27497425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and fundamental studies on ceftriaxone (CTRX) against urinary tract infections].
    Nishio S; Yoshihara H
    Hinyokika Kiyo; 1988 May; 34(5):937-42. PubMed ID: 3177133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible choreoathetosis after the administration of ceftriaxone sodium in patients with end-stage renal disease.
    Sato Y; Morita H; Wakasugi H; Iijima S; Kawashima E; Wakayama Y; Yoshimura A
    Am J Med Sci; 2010 Nov; 340(5):382-4. PubMed ID: 20724905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of ceftriaxone-associated pseudolithiasis in an adult patient that disappeared after the discontinuation of ceftriaxone].
    Tomoda T; Ueki T; Saito S; Tatsukawa M; Nawa T; Hamamoto H; Endo H; Yabushita K; Shimoe T; Sakaguchi K
    Nihon Shokakibyo Gakkai Zasshi; 2013 Aug; 110(8):1481-6. PubMed ID: 23912008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of ceftriaxone in the treatment of neonatal infections].
    Okura K; Yamamoto H; Yamaoka K; Kubo K; Mitsuyoshi I; Haruta T; Kobayashi Y
    Jpn J Antibiot; 1988 Feb; 41(2):152-64. PubMed ID: 3286924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible Ceftriaxone-Induced Pseudolithiasis in an Adult Patient with Maintenance Hemodialysis.
    Shima A; Suehiro T; Takii M; Soeda H; Hirakawa M
    Case Rep Nephrol Dial; 2015; 5(3):187-91. PubMed ID: 26558252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of ceftriaxone based on population pharmacokinetics and the prediction of efficacy in Japanese adults.
    Iida S; Kinoshita H; Kawanishi T; Hayashi M
    Eur J Drug Metab Pharmacokinet; 2009; 34(2):107-15. PubMed ID: 19645220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone-Related Encephalopathy in a Patient With End-Stage Renal Disease and High Ceftriaxone Concentrations in Cerebrospinal Fluid and Plasma: A Case Report.
    Takano T; Kaburagi M; Morikubo S; Ichikawa D; Matsumoto K
    Cureus; 2023 Oct; 15(10):e46401. PubMed ID: 37927711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic and clinical evaluations of ceftriaxone in neonates and premature infants].
    Motohiro T; Oda K; Aramaki M; Tanaka K; Kawakami A; Shimada Y; Koga T; Tomita S; Sakata Y; Fujimoto T
    Jpn J Antibiot; 1988 Mar; 41(3):276-305. PubMed ID: 3404647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone-associated Pseudolithiasis in the Gallbladder and Bile Duct of an Elderly Patient.
    Yamabe A; Irisawa A; Wakabayashi H; Tsunoda T; Tominaga K
    Intern Med; 2020 Nov; 59(21):2725-2728. PubMed ID: 32669492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental verification of factors influencing calcium salt formation based on a survey of the development of ceftriaxone-induced gallstone-related disorder.
    Ito R; Yoshida A; Taguchi K; Enoki Y; Yokoyama Y; Matsumoto K
    J Infect Chemother; 2019 Dec; 25(12):972-978. PubMed ID: 31186195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden-onset gallbladder rupture due to Ceftriaxone-associated pseudolithiasis in a patient with acquired hemophilia A.
    Harada N; Shibano I; Mukai D; Kizawa Y; Shiragami H; Takayanagi S; Hosaka N; Mugitani A; Hino M
    J Infect Chemother; 2023 Aug; 29(8):796-799. PubMed ID: 37075980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encephalopathy Induced by High Plasma and Cerebrospinal Fluid Ceftriaxone Concentrations in a Hemodialysis Patient.
    Suzuki S; Naito S; Numasawa Y; Asada M; Shoji N; Zeniya M; Takahashi D; Sato H; Iimori S; Nomura N; Sohara E; Okado T; Ishiwata Y; Nagata M; Rai T; Yokota T; Uchida S
    Intern Med; 2019 Jun; 58(12):1775-1779. PubMed ID: 30799339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections.
    Tsukagoshi S; Ishizawa K; Hirayanagi K; Nagamine S; Makioka K; Fujita Y; Ikeda Y
    Intern Med; 2017 Dec; 56(23):3189-3192. PubMed ID: 29021458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteriological, pharmacokinetic and clinical evaluations of ceftriaxone in the pediatric field. Pediatric study group of ceftriaxone].
    Fujii R; Meguro H; Arimasu O; Tagaya M; Fujita K; Sakata H; Yoshioka H; Maruyama S; Sanae N; Nagamatsu I
    Jpn J Antibiot; 1986 Aug; 39(8):1988-2008. PubMed ID: 3540338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and bacteriological evaluation of ceftriaxone (CTRX) dosed once daily in children with community-acquired pneumonia].
    Toyonaga Y; Kanemura H; Kitano M; Mitsui Y; Ishihara T; Hoshiai M; Ohno R
    Jpn J Antibiot; 1999 Apr; 52(4):322-32. PubMed ID: 10396689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical efficacy of ceftriaxone when administered once daily for respiratory tract infections in patients with advanced ages].
    Takizawa S; Yanase K; Hashizume I; Kasamatsu N; Tachibana A; Ogisu N; Okazawa M
    Jpn J Antibiot; 1992 Jun; 45(6):681-6. PubMed ID: 1507399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic and clinical studies on ceftriaxone in the perinatal period].
    Hirabayashi K; Okada E
    Jpn J Antibiot; 1988 Feb; 41(2):216-24. PubMed ID: 3373742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.